Evidence map›Paper›PMID 31105843›Full record

ArticleAmerican journal of translational research2019

Combination of cetuximab with met inhibitor in control of cetuximab-resistant oral squamous cell carcinoma.

Hua Yang, Chuzi Mo, Yang Xun, Leyna G Liu, Wenxing Li, Jieying Guan, Jing Liu, Jianquan Wu, Anping Yang, Songguo Zheng and 2 more

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Hua YangDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Chuzi MoDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Yang XunDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Leyna G LiuPortola High School 1001 Cadence, Irvine, CA 92618, U.S.A.
Wenxing LiThe Key Laboratory of Animal Models and Human Disease Mechanisms, Kunming Institute of Zoology, Chinese Academy of Sciences Kunming 650223, Yunnan, China.
Jieying GuanDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Jing LiuDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Jianquan WuDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Anping YangDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Songguo ZhengDepartment of Medicine, Division of Rheumatology, Milton S. Hershey Medical Center at Penn State University Hershey, PA 17033, USA.
Dahai LiuDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Fang LiuDepartment of Basic Medicine and Biomedical Engineering, School of Stomatology and Medicine, Foshan University Foshan 528000, Guangdong, China.
Foshan University · CNCadence Design Systems (United States) · USKunming Institute of Botany · CNPenn State Milton S. Hershey Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aktcetuximab resistanceERK1/2HGFMetOral squamous cell carcinoma

Identifiers

PMID31105843
PMCPMC6511799
OpenAlexW2980786348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.